Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Google Inc (GOOG) vs Johnson & Johnson (JNJ) Price & Performance

Google IncTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Google Inc vs Johnson & Johnson — how do they compare? Google Inc trades at $369.93 (market cap $4.52T), while Johnson & Johnson trades at $249.78 (market cap $594.63B). The key difference: Google Inc is far larger — about 7.6× Johnson & Johnson's market cap, and Johnson & Johnson pays the higher dividend (2.17%). Which is the better fit depends on your goals.

GOOGJNJ
Market Cap
$4.52T$594.63B
Volume
1,511,1276,156,228
Sector
TechnologyHealth
52-Week High
$399.06$267.24
52-Week Low
$183.77$162.98
Enterprise Value
$4.49T$627.57B
Dividend Yield
0.24%2.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

Alphabet (GOOG) trades at $370.43, up 3.67% on the day, with strong bullish momentum from recent earnings beats and a consensus analyst price target of $457.50. The stock shows robust fundamentals with 2025 revenue of $402.84B, net income margin of 37.92%, and consistent cash flow growth. Technical indicators are bullish, with the current price near resistance at $374, while sentiment is positive due to Warren Buffett's recent endorsement and AI-driven growth prospects.

Outlook remains favorable with earnings growth and AI expansion as key catalysts, though regulatory risks and market volatility pose challenges. The stock offers upside potential aligned with analyst targets, supported by high institutional ownership and strong profitability metrics.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $249.42, down 1.75% over 24 hours, with a bullish technical signal from moving averages but bearish oscillators. The company reported Q2 2026 EPS of $2.90, beating estimates, and raised full-year guidance. Revenue grew 6.6% annually, supported by strong pharmaceutical sales. Analyst consensus is bullish with a $281 price target, and the stock offers a stable dividend with recent payouts of $1.34 per share.

Outlook remains positive due to robust fundamentals, innovation in medtech and pharmaceuticals, and dividend king status. Risks include patent expirations, regulatory pressures, and macroeconomic volatility. The current valuation at P/E 28.66 may limit near-term upside, but long-term growth prospects appear solid.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

Read more on GOOG

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ